1. Home
  2. UTF vs LIVN Comparison

UTF vs LIVN Comparison

Compare UTF & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$28.00

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo LivaNova PLC

LIVN

LivaNova PLC

HOLD

Current Price

$78.17

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTF
LIVN
Founded
N/A
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.5B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
UTF
LIVN
Price
$28.00
$78.17
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$72.43
AVG Volume (30 Days)
241.9K
622.0K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
N/A
N/A
Revenue This Year
N/A
$9.79
Revenue Next Year
N/A
$6.63
P/E Ratio
N/A
$196.53
Revenue Growth
N/A
N/A
52 Week Low
$23.42
$41.02
52 Week High
$28.11
$85.27

Technical Indicators

Market Signals
Indicator
UTF
LIVN
Relative Strength Index (RSI) 62.65 43.69
Support Level $26.54 $61.63
Resistance Level $28.11 $80.96
Average True Range (ATR) 0.29 2.31
MACD 0.00 -0.78
Stochastic Oscillator 82.89 27.67

Price Performance

Historical Comparison
UTF
LIVN

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: